Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 3/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | RAPGEF4 | Q8WZA2 | 3/20 | 0.36 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.35 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.33 |
| ▸ | TUBB1 | Q9H4B7 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.32 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.32 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.32 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.32 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.32 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.32 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.32 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30867032 | 1.00 | ACHE (0.42) | ACHECYP3A4TSHRMAPK1RAPGEF4 | |
| SCHEMBL18867947 | 0.85 | CYP3A4 (0.40) | ACHECYP3A4TSHRMAPK1RAPGEF4 | |
| SCHEMBL823783 | 0.85 | ACHE (0.38) | ACHERAPGEF4NFE2L2PTGS2PTGS1 | |
| SCHEMBL1057045 | 0.85 | CYP3A4 (0.40) | ACHECYP3A4TSHRMAPK1RAPGEF4 | |
| SCHEMBL30166047 | 0.85 | CYP3A4 (0.40) | ACHECYP3A4TSHRMAPK1RAPGEF4 | |
| SCHEMBL261036 | 0.83 | ACHE (0.42) | ACHECYP3A4TSHRMAPK1RAPGEF4 | |
| Hydrochloric Acid SCHEMBL29178225 | 0.82 | ACHE (0.36) | ACHERAPGEF4NFE2L2PTGS2PTGS1 | |
| Bromide SCHEMBL28031443 | 0.82 | ACHE (0.36) | ACHERAPGEF4NFE2L2PTGS2PTGS1 | |
| SCHEMBL810964 | 0.82 | ACHE (0.36) | ACHECYP3A4TSHRMAPK1RAPGEF4 | |
| Methyl Alcohol SCHEMBL28273171 | 0.79 | DAO (0.36) | ACHERAPGEF4NFE2L2PTGS2PTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 149 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2007054213-A1 | PROCESS FOR CONTINUOUSLY PREPARING DIFLUOROBENZENE DERIVATIVES WITH LONG OPERATING TIMES | BAYER TECHNOLOGY SERVICES GMBH (DE) | 2007-05-18 | — | — | WO | claimed |
| CN-117964544-A | Synthetic method of isoindoline derivatives | 上海吉奉生物科技有限公司 | 2024-05-03 | — | — | CN | disclosed |
| US-11916180-B2 | Organic solar cell and photodetector materials and devices | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-02-27 | — | — | US | disclosed |
| US-11916180-B2 | Organic solar cell and photodetector materials and devices | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-02-27 | — | — | US | disclosed |
| US-20230371357-A1 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-11-16 | — | — | US | disclosed |
| US-20230312481-A1 | SUBSTITUTED (PHTHALAZIN-1-YLMETHYL)UREAS, SUBSTITUTED N-(PHTHALAZIN-1-YLMETHYL)AMIDES, AND ANALOGUES THEREOF | ARBUTUS BIOPHARMA CORP (CA) | 2023-10-05 | — | — | US | disclosed |
| WO-2023162852-A1 | SECONDARY BATTERY ELECTROLYTE AND SECONDARY BATTERY | 株式会社村田製作所 | 2023-08-31 | — | — | WO | disclosed |
| US-20230263056-A1 | ORGANIC SOLAR CELL AND PHOTODETECTOR MATERIALS AND DEVICES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-08-17 | — | — | US | disclosed |
| US-20230263056-A1 | ORGANIC SOLAR CELL AND PHOTODETECTOR MATERIALS AND DEVICES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-08-17 | — | — | US | disclosed |
| EP-4227307-A1 | PYRAZOLOPYRAZINE COMPOUNDS AS SHP2 INHIBITORS | Genzyme Corporation (US) | 2023-08-16 | — | — | EP | disclosed |
| WO-2007054213-A1 | PROCESS FOR CONTINUOUSLY PREPARING DIFLUOROBENZENE DERIVATIVES WITH LONG OPERATING TIMES | BAYER TECHNOLOGY SERVICES GMBH (DE) | 2007-05-18 | — | — | WO | disclosed |
| US-7214763-B2 | Electroactive fluorene copolymers and devices made with such polymers | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-05-08 | — | — | US | disclosed |
| US-7211643-B2 | Electroactive fluorene copolymers and devices made with such polymers | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-05-01 | — | — | US | disclosed |
| US-7183366-B2 | Aromatic copolymers from dihalofluorene compounds and another dihalo- or diborono- aromatic monomers; organic electroluminescent polymers for use in light-emitting diodes | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-02-27 | — | — | US | disclosed |
| EP-1094053-B1 | Method of preparing fluoroaromatic compounds | ZELINSKY INST OF ORGANIC CHEMI (RU) | 2003-05-21 | — | — | EP | disclosed |
| EP-1094053-A1 | Method of preparing fluoroaromatic compounds | Zelinsky Institute of Organic Chemistry (RU) | 2001-04-25 | — | — | EP | disclosed |
| US-6008407-A | REACTING CHLOROTRIFLUOROETHYLENE AND 1,3-BUTADIENE TO PRODUCE CHLOROTRIFLUOROCYCLOHEXENES, DEHYDROHALOGENATING THE MIXTURE OF CYCLOHEXENES WITH PHASE TRANSFER CATALYST IN PRESENCE OF ALKALI METAL HYDROXIDE WITHOUT SOLVENT | ZELINSKY INSTITUTE OF ORGANIC CHEMISTRY (RU) | 1999-12-28 | — | — | US | disclosed |
| EP-0285324-B1 | PREPARATION OF SUBSTITUTED FLUOROBENZENES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1991-11-27 | — | — | EP | disclosed |
| EP-0285324-A1 | Preparation of substituted fluorobenzenes | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1988-10-05 | — | — | EP | disclosed |
| US-4754084-A | PYROLYSIS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1988-06-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230263056-A1 | ORGANIC SOLAR CELL AND PHOTODETECTOR MATERIALS AND DEVICES | OCIAD1, OCIAD2, CDH1 | ACHE 4455/4885CYP3A4 1909/4885TSHR 4708/4885 |
| US-20230371357-A1 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE | L1CAM, CHRM1, FOXM1 | ACHE 574/4885CYP3A4 256/4885TSHR 2605/4885 |
| US-20230312481-A1 | SUBSTITUTED (PHTHALAZIN-1-YLMETHYL)UREAS, SUBSTITUTED N-(PHTHALAZIN-1-YLMETHYL)AMIDES, AND ANALOGUES THEREOF | NSD3, PML, NSD1 | ACHE 4527/4885CYP3A4 1684/4885TSHR 3398/4885 |
| US-11916180-B2 | Organic solar cell and photodetector materials and devices | OCIAD1, OCIAD2, CDH1 | ACHE 4455/4885CYP3A4 1909/4885TSHR 4708/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.